Si-Bone (SIBN) Net Equity Issued and Repurchased (2020 - 2023)
Si-Bone (SIBN) posted quarterly Net Equity Issued and Repurchased of -$466000.0 for Q3 2023, down 100.65% quarter-over-quarter from $71.6 million in Q4 2020.
Si-Bone (SIBN) Net Equity Issued and Repurchased (2020 - 2023) Analysis & Trends
Si-Bone's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at -$466000.0 for Q3 2023.
- In Q3 2023, Net Equity Issued and Repurchased changed N/A year-over-year to -$466000.0; the TTM figure through Dec 2024 stood at -$466000.0 (changed 0.0% YoY), while the FY2023 annual figure was $83.7 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q3 2023 stood at -$466000.0, down from $71.6 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $71.6 million in Q4 2020, with the low at -$466000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Si-Bone | 868.19 Mn | 722.25 Mn | 44.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -466,000.00 |
| Sep 30, 2023 | -466,000.00 |
| Dec 31, 2020 | 71.64 Mn |
| Dec 31, 2020 | 71.64 Mn |
| Mar 31, 2020 | 62.98 Mn |
| Mar 31, 2020 | 62.98 Mn |